| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd47318319f20f7f99d9fef1fd3e511b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2878
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F5-04 |
| filingDate |
2017-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e336097aef2bf9b92e49277837f69c6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4350223bf238ae83c67152546188e90f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9dd82dda918f362e8dc24b2b70622bd8 |
| publicationDate |
2018-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2018027022-A1 |
| titleOfInvention |
Combination of proteasome inhibitors and anti-cd30 antibodies |
| abstract |
The present invention relates to methods for the treatment of cancers. In particular, the invention provides methods for treatment of cancer by administering a proteasome inhibitor in combination with an anti-CD30 antibody. |
| priorityDate |
2016-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |